References
- ForestierJ. La Chrysotherapie dans les Rhum atism es Chroniques. Bull Mem Soc Med des H op de Paris 1929; 44: 323–9.
- Forestier J. Rheumatoid arthritis and its treatm ent by gold salts. J Lab Clin Med 1935; 20: 827–40.
- Em pire Rheumatism Council. Gold therapy in rheumatoid arthritis. Final report of a multicenter controlled trial. Ann Rheum D is 1961; 20: 315–24.
- Geddes DM, Brostoff J. Pulmonary ®brosis associated with hypersensitivity to gold salts. BMJ 1976; 1: 1444.
- Gould PW, McCorm ack PL, Palmer DG. Pulmonary dam age associated w ith sodium aurothiomalate therapy. J Rheumatol 1977; 3: 181–2.
- Scott DL, Bradby G V, Aitm an TJ, et al. Relationship of gold and penicillamine therapy to diffuse intestinal lung disease. Ann Rheum D is 1981; 40: 136–41.
- Belleli A, Boiardi L, Turniad B, et al. D iffuse intestinal lung disease associated w ith hypersensitivity to gold salt. Clin Exp Rheum atol 1985; 3: 181–2.
- Kay AGL. Myelotoxicity of gold. Br Med J 1976; I: 1266–8.
- Coblyn JS, W einblatt M, Holdsworth D, et al. Gold induced thrombocytopaenia; a clinical and imm unogenetic study of twenty-three patients. Ann Intern Med 1981; 95: 178–81.
- Adachi JD, Benson W G, Kassam Y. Gold induced thrombocytopaenia; 12 cases and a review of the literature. Sem Arthritis Rheum 1987; 16: 287–93.
- Am os RS, Bax DE. Leucopaenia in rheum atoid arthritis: relationship to gold or sulphasalazine therapy. Br J Rheum atol 1988; 27: 465–8.
- Madhok R, Pullar T, Capell H A, et al. Chrysotherapy and thrombocytopenia. Ann Rheumatol Dis 1985; 44: 589–91.
- Epstein W V, Henke CJ, Yelin E H, et al. Effect of parenterally administered gold therapy on the course of adult rheumatoid arthritis. Ann Intern Med 1991; 114: 437–44.
- Finkelstein AE, W alz DT, Batista V, et al. Aurano®n: new oral gold com pound for treatment of rheumatoid arthritis. Ann Rheum Dis 1976; 35: 251–7.
- Pearson RG: hard and soft acids and bases. J Am Chem Soc 1963; 85: 3533–9.
- Maclagan N F. The preparation and use of colloidal gold sols as diagnostic agents. J Exp Pathol 1947; 27: 369–77.
- Frens G. Controlled nucleation for the regulation of the particle size in monodisperse gold suspen- sions. N ature Phys Sci 1973; 241: 20–2.
- Goldstein A. Biostatics: an introductory text. New Y ork: T he Macm illan Company, 1964.
- Pincus T, Summ ey JA, Soraci SA Jr, et al. Assessment of patient satisfaction in activities of daily living using a m odi®ed Stanford health assessment questionnaire. A rthritis Rheum 1983; 26: 1346–53.
- Lansbury J. Quantitation of the activity of rheum atoid arthritis 1956; 232: 300–10.
- Am erican Rheumatology Association. Dictionary of Rheumatic Diseases, V olume I. Signs and Sym ptom s. New Y ork: Contact A ssociates International Ltd, 1982.
- Steinbrocker O, Traeger CH, Batterman, RC. Therapeutic m easurement in rheum atoid arthritis. JAMA 1949; 140: 659–62.
- Juurlink BHJ, Devon RM. Colloidal gold as a perm anent m arker of cells. E xperientia 1991; 47: 75–7.
- Danien BJ, Sim s PA, K ruse-Elliott K T, et al. Use of Colloidal gold and neutron activation in correlative microscopic labeling and label quantitation. Scanning Microscopy 1995; 9: 773–80.
- Roberts VB, D ore JL, Jessop JD et al. Selective concentration and localization of gold in m acrophages of synovial and other tissues during and after chrysotherapy in rheumatoid patients. A nn Rheum Dis 1976; 35: 477–86.
- Ghadially FN, Oryschak AF, Mitchell D M. Ultrastructural changes produced in rheum atoid synovial m em brane by chrysotherapy. Ann Rheum D is 1976; 35: 67–72.
- Kligman AM. The identi®cation of contact allergans by hum an assay. III. The maxim ization test: a procedure for screening and rating contact sensitizers. J Invest Dermatol 1966; 47: 393–409.
- Hardcastle J, Hardcastle PT, K elleher DK. Effect of aurano®n on ion transport by rat small intestine. J Pharm Pharmacol 1989; 41: 817–23.
- Lockie LM, Smith DM. Forty-seven years experience with gold therapy in 1019 rheum atoid arthritis patients. Sem A rthritis Rheum 1985; 14: 238–46.
- Panayi GS. New ideas on the pathogenesis of rheum atoid arthritis. Ann Ital Med Int 1990; 5: 1–4.
- Kavanaugh AF, Lipsky PE. Gold, penicillam ine, antimalarials, and sulfasalazine. In: G allin JT, Goldstein IM, Snyderm an R, eds. In¯amm ation. New Y ork: Raven Press, 1992; 1083–101.
- Robinson CJG, Balazs T, Egorov JK. Mercuric chloride-gold sodium thiomalate- and D-penicillam ine- induced antinuclear antibodies in mice. Toxicol Appl Pharm acol 1986; 86: 159–69.
- Pietsch P, Vohr BW, D egitz K, et al. Im munological alterations inducible by mercury com pounds, II. HgCI3 and gold sodium thiomalate enhance serum IgE and IgG concentrations in susceptible mouse strains. Int Arch A llergy A ppl Imm unol 1989; 90: 47–53.
- Schuhm ann D, Kubieka-M uranyi M, Mirtschewa J, et al. Adverse im mune reactions to gold. I. Chronic treatment w ith an A u (I) drug sensitizes mouse T cells not to A u (I), but to A u (III) and induces autoantibody formation. J Imm unol 1990; 145: 2132–9.
- Goebel C, Kubieka-M uranyi M, Tonn T, et al. Phagocytes render chem icals im munogenic: oxidation of gold (I) to the T cell-sensitizing gold (III) m etabolite generated by mononuclear phagocytes. Arch Toxicol 1995; 69: 450–9.
- Freund PL, Spiro M. Colloidal catalysis: the effect of sol size and concentration. J Phys Chem 1985; 89: 1074–7.